Investor Temperature Check: What’s Hot and What’s Not in CGT?
Thursday, May 30, 2024 03:45 PM - 04:45 PM
Room 205-207
Roundtable
Moderator
Key Learning Objectives
1. What types of products and technologies investors are most interested in deploying capital towards 2. Areas within CGT that investors are shying away from based on clinical, regulatory or commercial challenges
3. How investment behaviour may evolve over the next several years
- Patrick Rivers, BS, MBA, Aquilo Capital Management, United States
- Jason Bock, PhD, CTMC, United States
- Nagisa Sakurai, PhD, MBA, Astellas Venture Management, LLC, United States
- Phil Vanek, PhD, Gamma Biosciences, United States
Key Learning Objectives
1. What types of products and technologies investors are most interested in deploying capital towards 2. Areas within CGT that investors are shying away from based on clinical, regulatory or commercial challenges
3. How investment behaviour may evolve over the next several years
